Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Capecitabine-induced headache responding to diltiazem.

Arun K Raman1, Marwan G Fakih

  • 1Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.

Chemotherapy
|May 31, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Utility of Circulating Tumor DNA to Assess Tumor Response in Patients with Locally Advanced Rectal Cancer Undergoing Neoadjuvant Therapy.

Cancers·2026
Same author

Baseline Tumor Features and Systemic Immune Dynamics Underlying Efficacy in MSS Metastatic Colorectal Cancer Treated with Regorafenib, Ipilimumab, and Nivolumab.

Cancer immunology research·2026
Same author

Reduced Floxuridine Dose Limits Hepatobiliary Toxicity Without Negatively Impacting Survival After Resection of Colorectal Cancer Liver Metastases.

Annals of surgical oncology·2025
Same author

Sotorasib in KRAS-Mutated Colorectal Cancer. Reply.

The New England journal of medicine·2024
Same author

Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial.

Nature medicine·2024
Same author

Efficacy and Safety of Trifluridine/Tipiracil-Containing Combinations in Colorectal Cancer and Other Advanced Solid Tumors: A Systematic Review.

The oncologist·2024

Severe headaches linked to capecitabine chemotherapy can be effectively treated with diltiazem. This calcium channel blocker offers a potential therapy for this rare but serious side effect, allowing patients to complete treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Gastroenterology

Background:

  • Headaches are a known side effect of capecitabine chemotherapy.
  • Severe headaches are rarely reported and lack established treatment protocols.

Observation:

  • A patient undergoing rectal adenocarcinoma treatment developed grade 3 capecitabine-induced headache.
  • Headache resolved upon capecitabine withdrawal and recurred upon rechallenge, suggesting a causal link.

Findings:

  • Diltiazem, a calcium channel blocker, effectively resolved the patient's severe headache.
  • The patient successfully completed capecitabine and radiation therapy without further adverse events.

Implications:

  • Capecitabine-induced headaches may be vascular in nature, potentially due to vasospasm.

Related Experiment Videos

  • Calcium channel blockers like diltiazem should be considered for managing capecitabine or 5-fluorouracil-induced headaches.